@article{beuscart_international_2018,
	title = {International core outcome set for clinical trials of medication review in multi-morbid older patients with polypharmacy},
	volume = {16},
	issn = {1741-7015},
	url = {https://doi.org/10.1186/s12916-018-1007-9},
	doi = {10.1186/s12916-018-1007-9},
	abstract = {Comparisons of clinical trial findings in systematic reviews can be hindered by the heterogeneity of the outcomes reported. Moreover, the outcomes that matter most to patients might be underreported. A core outcome set can address these issues, as it defines a minimum set of outcomes that should be reported in all clinical trials in a particular area of research. The objective in this study was to develop a core outcome set for clinical trials of medication review in multi-morbid older patients with polypharmacy.},
	number = {1},
	urldate = {2019-03-07},
	journal = {BMC Medicine},
	author = {Beuscart, Jean-Baptiste and Knol, Wilma and Cullinan, Shane and Schneider, Claudio and Dalleur, Olivia and Boland, Benoit and Thevelin, Stefanie and Jansen, Paul A. F. and O’Mahony, Denis and Rodondi, Nicolas and Spinewine, Anne},
	month = feb,
	year = {2018},
	pages = {21},
}

{"_id":"Dfy6wd6xGW5njAuDZ","bibbaseid":"beuscart-knol-cullinan-schneider-dalleur-boland-thevelin-jansen-etal-internationalcoreoutcomesetforclinicaltrialsofmedicationreviewinmultimorbidolderpatientswithpolypharmacy-2018","author_short":["Beuscart, J.","Knol, W.","Cullinan, S.","Schneider, C.","Dalleur, O.","Boland, B.","Thevelin, S.","Jansen, P. A. F.","O’Mahony, D.","Rodondi, N.","Spinewine, A."],"bibdata":{"bibtype":"article","type":"article","title":"International core outcome set for clinical trials of medication review in multi-morbid older patients with polypharmacy","volume":"16","issn":"1741-7015","url":"https://doi.org/10.1186/s12916-018-1007-9","doi":"10.1186/s12916-018-1007-9","abstract":"Comparisons of clinical trial findings in systematic reviews can be hindered by the heterogeneity of the outcomes reported. Moreover, the outcomes that matter most to patients might be underreported. A core outcome set can address these issues, as it defines a minimum set of outcomes that should be reported in all clinical trials in a particular area of research. The objective in this study was to develop a core outcome set for clinical trials of medication review in multi-morbid older patients with polypharmacy.","number":"1","urldate":"2019-03-07","journal":"BMC Medicine","author":[{"propositions":[],"lastnames":["Beuscart"],"firstnames":["Jean-Baptiste"],"suffixes":[]},{"propositions":[],"lastnames":["Knol"],"firstnames":["Wilma"],"suffixes":[]},{"propositions":[],"lastnames":["Cullinan"],"firstnames":["Shane"],"suffixes":[]},{"propositions":[],"lastnames":["Schneider"],"firstnames":["Claudio"],"suffixes":[]},{"propositions":[],"lastnames":["Dalleur"],"firstnames":["Olivia"],"suffixes":[]},{"propositions":[],"lastnames":["Boland"],"firstnames":["Benoit"],"suffixes":[]},{"propositions":[],"lastnames":["Thevelin"],"firstnames":["Stefanie"],"suffixes":[]},{"propositions":[],"lastnames":["Jansen"],"firstnames":["Paul","A.","F."],"suffixes":[]},{"propositions":[],"lastnames":["O’Mahony"],"firstnames":["Denis"],"suffixes":[]},{"propositions":[],"lastnames":["Rodondi"],"firstnames":["Nicolas"],"suffixes":[]},{"propositions":[],"lastnames":["Spinewine"],"firstnames":["Anne"],"suffixes":[]}],"month":"February","year":"2018","pages":"21","bibtex":"@article{beuscart_international_2018,\n\ttitle = {International core outcome set for clinical trials of medication review in multi-morbid older patients with polypharmacy},\n\tvolume = {16},\n\tissn = {1741-7015},\n\turl = {https://doi.org/10.1186/s12916-018-1007-9},\n\tdoi = {10.1186/s12916-018-1007-9},\n\tabstract = {Comparisons of clinical trial findings in systematic reviews can be hindered by the heterogeneity of the outcomes reported. Moreover, the outcomes that matter most to patients might be underreported. A core outcome set can address these issues, as it defines a minimum set of outcomes that should be reported in all clinical trials in a particular area of research. The objective in this study was to develop a core outcome set for clinical trials of medication review in multi-morbid older patients with polypharmacy.},\n\tnumber = {1},\n\turldate = {2019-03-07},\n\tjournal = {BMC Medicine},\n\tauthor = {Beuscart, Jean-Baptiste and Knol, Wilma and Cullinan, Shane and Schneider, Claudio and Dalleur, Olivia and Boland, Benoit and Thevelin, Stefanie and Jansen, Paul A. F. and O’Mahony, Denis and Rodondi, Nicolas and Spinewine, Anne},\n\tmonth = feb,\n\tyear = {2018},\n\tpages = {21},\n}\n\n","author_short":["Beuscart, J.","Knol, W.","Cullinan, S.","Schneider, C.","Dalleur, O.","Boland, B.","Thevelin, S.","Jansen, P. A. F.","O’Mahony, D.","Rodondi, N.","Spinewine, A."],"key":"beuscart_international_2018","id":"beuscart_international_2018","bibbaseid":"beuscart-knol-cullinan-schneider-dalleur-boland-thevelin-jansen-etal-internationalcoreoutcomesetforclinicaltrialsofmedicationreviewinmultimorbidolderpatientswithpolypharmacy-2018","role":"author","urls":{"Paper":"https://doi.org/10.1186/s12916-018-1007-9"},"metadata":{"authorlinks":{}}},"bibtype":"article","biburl":"https://api.zotero.org/users/576834/collections/NYCBQQBB/items?key=MJNBdUsYThALl7viNVVbkecN&format=bibtex&limit=100","dataSources":["KcAAuaxski6XBszw2"],"keywords":[],"search_terms":["international","core","outcome","set","clinical","trials","medication","review","multi","morbid","older","patients","polypharmacy","beuscart","knol","cullinan","schneider","dalleur","boland","thevelin","jansen","o’mahony","rodondi","spinewine"],"title":"International core outcome set for clinical trials of medication review in multi-morbid older patients with polypharmacy","year":2018}